Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic...

Por Gillmore, Julian D, Falk, Rodney H, Maurer, Mathew S, Hanna, Mazen, Karsten, Verena, Vest, John, Gollob, Jared, Hawkins, Philip N
Publicado no Orphanet J Rare Dis (2015)

An Engineered Version of Human PON2 Opens the Way to Understand the Role of Its Post-Translational Modifications in Modulating Catalytic Activity

Por Mandrich, Luigi, Cerreta, Mariangela, Manco, Giuseppe
Publicado no PLoS One (2015)

Combining two open source tools for neural computation (BioPatRec and Netlab) improves movement classification for prosthetic control

Por Prahm, Cosima, Eckstein, Korbinian, Ortiz-Catalan, Max, Dorffner, Georg, Kaniusas, Eugenijus, Aszmann, Oskar C.
Publicado no BMC Res Notes (2016)

A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma

Por Greten, Tim F, Forner, Alejandro, Korangy, Firouzeh, N'Kontchou, Gisele, Barget, Nathalie, Ayuso, Carmen, Ormandy, Lars A, Manns, Michael P, Beaugrand, Michel, Bruix, Jordi
Publicado em 2010

Analysis of enzymatic digestion pattern of two open reading frames of Varciella–Zoster genome from Kuwaiti patients using the RFLP technique

Por JA, Qasem, Al-Fadhli, MA, Saraya, MA, Thomas, J
Publicado em 2012

Phase II, Open-Label, Randomized Trial of the MEK1/2 Inhibitor Selumetinib as Monotherapy versus Temozolomide in Patients with Advanced Melanoma

Por Kirkwood, John M., Bastholt, Lars, Robert, Caroline, Sosman, Jeff, Larkin, James, Hersey, Peter, Middleton, Mark, Cantarini, Mireille, Zazulina, Victoria, Kemsley, Karin, Dummer, Reinhard
Publicado em 2011

Long-term Opioid Blockade and Hedonic Response: Preliminary Data from Two Open-Label Extension Studies with Extended-Release Naltrexone

Por O’Brien, Charles P., Gastfriend, David R., Forman, Robert F., Schweizer, Edward, Pettinati, Helen M.
Publicado em 2010

Phase II open-label study of recombinant circularly permuted TRAIL as a single-agent treatment for relapsed or refractory multiple myeloma

Por Leng, Yun, Qiu, Lugui, Hou, Jian, Zhao, Yaozhong, Zhang, Xuejun, Yang, Shifang, Xi, Hao, Huang, Zhongxia, Pan, Ling, Chen, Wenming
Publicado no Chin J Cancer (2016)

Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis

Por Mascarenhas, John O., Talpaz, Moshe, Gupta, Vikas, Foltz, Lynda M., Savona, Michael R., Paquette, Ronald, Turner, A. Robert, Coughlin, Paul, Winton, Elliott, Burn, Timothy C., O’Neill, Peter, Clark, Jason, Hunter, Deborah, Assad, Albert, Hoffman, Ronald, Verstovsek, Srdan
Publicado no Haematologica (2017)

Evaluating the Effectiveness of Implementing a More Severe Drunk-Driving Law in China: Findings from Two Open Access Data Sources

Por Xiao, Wangxin, Ning, Peishan, Schwebel, David C., Hu, Guoqing
Publicado no Int J Environ Res Public Health (2017)

Clinically Effective Treatment of Fibromyalgia Pain With High-Definition Transcranial Direct Current Stimulation: Phase II Open-Label Dose Optimization

Por Castillo-Saavedra, Laura, Gebodh, Nigel, Bikson, Marom, Diaz-Cruz, Camilo, Brandao, Rivail, Coutinho, Livia, Truong, Dennis, Datta, Abhishek, Shani-Hershkovich, Revital, Weiss, Michal, Laufer, Ilan, Reches, Amit, Peremen, Ziv, Geva, Amir, Parra, Lucas C., Fregni, Felipe
Publicado no J Pain (2015)

Apatinib in Patients with Relapsed or Refractory Diffuse Large B Cell Lymphoma: A Phase II, Open-Label, Single-Arm, Prospective Study

Por Ma X, Li L, Zhang L, Fu X, Li X, Wang X, Wu J, Sun Z, Zhang X, Feng X, Chang Y, Zhou Z, Nan F, Zhang J, Li Z, Zhang M
Publicado em 2020-01-01

Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Por Byrski, Tomasz, Dent, Rebecca, Blecharz, Pawel, Foszczynska-Kloda, Malgorzata, Gronwald, Jacek, Huzarski, Tomasz, Cybulski, Cezary, Marczyk, Elzbieta, Chrzan, Robert, Eisen, Andrea, Lubinski, Jan, Narod, Steven A
Publicado em 2012

Effects of Prophylactic and Therapeutic Paracetamol Treatment during Vaccination on Hepatitis B Antibody Levels in Adults: Two Open-Label, Randomized Controlled Trials

Por Doedée, Anne M. C. M., Boland, Greet J., Pennings, Jeroen L. A., de Klerk, Arja, Berbers, Guy A. M., van der Klis, Fiona R. M., de Melker, Hester E., van Loveren, Henk, Janssen, Riny
Publicado em 2014

Local Heat Application for the Treatment of Buruli Ulcer: Results of a Phase II Open Label Single Center Non Comparative Clinical Trial

Por Vogel, Moritz, Bayi, Pierre F., Ruf, Marie-Thérèse, Bratschi, Martin W., Bolz, Miriam, Um Boock, Alphonse, Zwahlen, Marcel, Pluschke, Gerd, Junghanss, Thomas
Publicado no Clin Infect Dis (2016)

Reduced Silent Occlusions with a Novel Catheter Infusion Set (BD FlowSmart): Results from Two Open-Label Comparative Studies

Por Gibney, Michael, Xue, Zhenyi, Swinney, Monica, Bialonczyk, Damian, Hirsch, Laurence
Publicado no Diabetes Technol Ther (2016)

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

Por Heyderman, Robert S, Madhi, Shabir A, French, Neil, Cutland, Clare, Ngwira, Bagrey, Kayambo, Doris, Mboizi, Robert, Koen, Anthonet, Jose, Lisa, Olugbosi, Morounfolu, Wittke, Frederik, Slobod, Karen, Dull, Peter M
Publicado no Lancet Infect Dis (2016)

Safety and efficacy of the choline analogue SAR97276 for malaria treatment: results of two phase 2, open-label, multicenter trials in African patients

Por Held, Jana, Supan, Christian, Salazar, Carmen L. Ospina, Tinto, Halidou, Bonkian, Léa Nadège, Nahum, Alain, Sié, Ali, Abdulla, Salim, Cantalloube, Cathy, Djeriou, Elhadj, Bouyou-Akotet, Marielle, Ogutu, Bernhards, Mordmüller, Benjamin, Kreidenweiss, Andrea, Siribie, Mohamadou, Sirima, Sodiomon B., Kremsner, Peter G.
Publicado no Malar J (2017)

Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma: Updated Results From a Phase 1/2 Open-label Study

Por Powles, Thomas, O'Donnell, Peter H., Massard, Christophe, Arkenau, Hendrik-Tobias, Friedlander, Terence W., Hoimes, Christopher J., Lee, Jae Lyun, Ong, Michael, Sridhar, Srikala S., Vogelzang, Nicholas J., Fishman, Mayer N., Zhang, Jingsong, Srinivas, Sandy, Parikh, Jigar, Antal, Joyce, Jin, Xiaoping, Gupta, Ashok K., Ben, Yong, Hahn, Noah M.
Publicado no JAMA Oncol (2017)

A phase 1/2, open-label assessment of the safety, tolerability, and efficacy of transdermal...

Por Helen Heussler, Jonathan Cohen, Natalie Silove, Nancy Tich, Marcel O. Bonn-Miller, Wei Du, Carol O’Neill, Terri Sebree
Publicado em 2019-08-01